Pulmatrix, Inc. (PULM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 5M 10M 15M Q1 '14: 0 Q2 '14: 0 Q3 '14: 30K Q4 '14: 30K Q1 '15: 135K Q2 '15: 305K Q3 '15: 926K Q4 '15: 1.2M Q1 '16: 1.5M Q2 '16: 1.6M Q3 '16: 992K Q4 '16: 834K Q2 '18: 488K Q3 '18: 153K Q4 '18: 306K Q1 '20: 10.7M Q2 '20: 9.4M Q3 '20: 12.3M Q4 '20: 12.6M Q1 '21: 11.3M Q2 '21: 10M Q3 '21: 6.7M Q4 '21: 5.2M Q1 '22: 4.9M Q2 '22: 4M Q3 '22: 4.8M Q4 '22: 6.1M Q1 '23: 6.4M Q2 '23: 6.9M Q3 '23: 6.8M Q4 '23: 7.3M Q1 '24: 11.7M Q2 '24: 11.4M Q3 '24: 10M Q4 '24: 7.8M Q1 '15 Q2 '16 Q4 '18 Q1 '21 Q2 '22 Q3 '23 Q4 '24

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-27M -18M -9M 0 9M 18M 27M Q1 '14: -3.1M Q2 '14: -5.1M Q3 '14: -6.7M Q4 '14: -7.8M Q1 '15: -9.5M Q2 '15: -18.4M Q3 '15: -20.4M Q4 '15: -23M Q1 '16: -25.7M Q2 '16: -23.4M Q3 '16: -21.7M Q4 '16: -24.9M Q1 '17: -22.7M Q2 '17: -19.2M Q3 '17: -20.5M Q4 '17: -17.5M Q1 '18: -19.3M Q2 '18: -20M Q3 '18: -20.5M Q4 '18: -21.2M Q1 '19: -21M Q2 '19: -22.8M Q3 '19: -21.7M Q4 '19: -20.7M Q1 '20: -20.5M Q2 '20: -13.7M Q3 '20: -11.3M Q4 '20: -9.9M Q1 '21: -9.2M Q2 '21: -11.9M Q3 '21: -18.8M Q4 '21: -20.2M Q1 '22: -21M Q2 '22: -21.8M Q3 '22: -18.7M Q4 '22: -18.9M Q1 '23: -18.6M Q2 '23: -18M Q3 '23: -16.8M Q4 '23: -14.7M Q1 '24: -9.4M Q2 '24: -11.3M Q3 '24: -10M Q4 '24: -9.8M Q1 '25: -12.4M Q2 '25: -8M Q3 '25: -6.2M Q4 '25: -5.2M Q1 '26: -4.6M Q2 '26: -4.1M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Net Income TTM

-45M -30M -15M 0 15M 30M 45M Q1 '14: -3.1M Q2 '14: -9.6M Q3 '14: -19.7M Q4 '14: -20.8M Q1 '15: -21.6M Q2 '15: -29.5M Q3 '15: -23.3M Q4 '15: -26.2M Q1 '16: -30M Q2 '16: -24.3M Q3 '16: -22.5M Q4 '16: -27.8M Q1 '17: -25.7M Q2 '17: -22.1M Q3 '17: -23.4M Q4 '17: -18.1M Q1 '18: -19.8M Q2 '18: -20.4M Q3 '18: -20.7M Q4 '18: -21.4M Q1 '19: -21.4M Q2 '19: -23M Q3 '19: -21.8M Q4 '19: -20.6M Q1 '20: -20.1M Q2 '20: -13.5M Q3 '20: -20.4M Q4 '20: -19.3M Q1 '21: -18.7M Q2 '21: -21.4M Q3 '21: -19M Q4 '21: -20.2M Q1 '22: -21M Q2 '22: -21.8M Q3 '22: -18.7M Q4 '22: -18.8M Q1 '23: -18.3M Q2 '23: -17.5M Q3 '23: -16.3M Q4 '23: -14.1M Q1 '24: -8.8M Q2 '24: -10.8M Q3 '24: -9.7M Q4 '24: -9.6M Q1 '25: -12.2M Q2 '25: -7.9M Q3 '25: -6.2M Q4 '25: -5.2M Q1 '26: -4.5M Q2 '26: -4M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q1 '14: -3M Q2 '14: -4.3M Q3 '14: -4.5M Q4 '14: -5.6M Q1 '15: -6.4M Q2 '15: -8.7M Q3 '15: -10.8M Q4 '15: -12.5M Q1 '16: -14.4M Q2 '16: -14.3M Q3 '16: -13.7M Q4 '16: -13.2M Q1 '17: -12.2M Q2 '17: -11.9M Q3 '17: -13.8M Q4 '17: -14.5M Q1 '18: -14.6M Q2 '18: -15.9M Q3 '18: -15.8M Q4 '18: -16.8M Q1 '19: -17.1M Q2 '19: 2.9M Q3 '19: 3.5M Q4 '19: 3.2M Q1 '20: 7.5M Q2 '20: -12.6M Q3 '20: -14.1M Q4 '20: -12.5M Q1 '21: -18.8M Q2 '21: -20.3M Q3 '21: -18.1M Q4 '21: -19.7M Q1 '22: -20.4M Q2 '22: -18.4M Q3 '22: -18.7M Q4 '22: -19.4M Q1 '23: -18.1M Q2 '23: -18.5M Q3 '23: -19M Q4 '23: -16M Q1 '24: -13.8M Q2 '24: -12.5M Q3 '24: -11.5M Q4 '24: -10.7M Q1 '25: -9.8M Q2 '25: -8M Q3 '25: -6M Q4 '25: -5.4M Q1 '26: -4.7M Q2 '26: -3.9M Q1 '14 Q4 '15 Q3 '17 Q2 '19 Q1 '21 Q4 '22 Q3 '24 Q2 '26

Free Cash Flow TTM

-21M -14M -7M 0 7M 14M 21M Q1 '15: -6.5M Q2 '15: -8.8M Q3 '15: -10.9M Q4 '15: -12.7M Q1 '16: -14.7M Q2 '16: -14.7M Q3 '16: -14.3M Q4 '16: -13.7M Q2 '19: 2.9M Q3 '19: 3.4M Q4 '19: 3.2M Q1 '20: 7.3M Q2 '20: -12.7M Q3 '20: -14.4M Q4 '20: -12.8M Q2 '22: -18.6M Q3 '22: -18.8M Q4 '22: -19.4M Q2 '24: -13.6M Q3 '24: -12.2M Q4 '24: -11.1M Q3 '15 Q2 '16 Q2 '19 Q1 '20 Q4 '20 Q4 '22 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 1.5B 3B 4.5B Q2 '21: 2.8M Q3 '21: 2.8M Q1 '22: 3.3M Q2 '22: 3.4B Q3 '22: 3.5B Q1 '23: 3.7M Q2 '23: 3.7M Q3 '23: 3.7M Q1 '24: 3.7M Q2 '24: 3.7M Q3 '24: 3.7M Q1 '25: 3.7M Q2 '25: 3.7M Q3 '25: 3.7M Q1 '26: 3.7M Q2 '26: 3.7M Q3 '21 Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-90.00 -60.00 -30.00 0.00 30.00 60.00 90.00 Q1 '14: -1.54 Q2 '14: -3.51 Q3 '14: -62.61 Q4 '14: -62.63 Q1 '15: -71.71 Q2 '15: -75.27 Q3 '15: -16.01 Q4 '15: -3.23 Q1 '16: 5.94 Q2 '16: 11.09 Q3 '16: 11.22 Q4 '16: -1.87 Q1 '17: -1.70 Q2 '17: -1.37 Q3 '17: -1.38 Q4 '17: -9.32 Q1 '18: -9.35 Q2 '18: -10.40 Q3 '18: -11.21 Q4 '18: -5.00 Q1 '19: -5.50 Q2 '19: -4.57 Q3 '19: -3.72 Q4 '19: -1.49 Q1 '20: -0.98 Q2 '20: -0.62 Q3 '20: -0.75 Q4 '20: -13.40 Q1 '21: -13.26 Q3 '23: -4.43 Q4 '23: -3.86 Q1 '24: -2.41 Q2 '24: -2.96 Q3 '24: -2.64 Q4 '24: -2.62 Q1 '25: -3.35 Q2 '25: -2.18 Q3 '25: -1.71 Q4 '25: -1.41 Q1 '26: -1.23 Q2 '26: -1.10 Q1 '15 Q3 '16 Q1 '18 Q3 '19 Q1 '21 Q4 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.